Synapse - Elsevier B.V.

Results (31)

Evaluation of early phase dose finding algorithms in heterogeneous populations

Journal Article

Clertant, M.; Iasonos, A.; O'Quigley, J.
Journal of Statistical Planning and Inference (2024)

Implementation and validation of an automated, longitudinal robotic surgical evaluation and feedback program at a high-volume center and impact on training

Journal Article

Wilcox Vanden Berg, R. N.; Vertosick, E. A.; Sjoberg, D. D.; Cha, E. K.; Coleman, J. A.; Donahue, T. F.; Eastham, J. A.; Ehdaie, B.; Laudone, V. P.; Pietzak, E. J.; more...
European Urology Open Science (2024)

Fulltext@MSK | Save

Quantifying interrater agreement and reliability between thoracic pathologists: Paradoxical behavior of Cohen's kappa in the presence of a high prevalence of the histopathologic feature in lung cancer

Journal Article

Tan, K. S.; Yeh, Y. C.; Adusumilli, P. S.; Travis, W. D.
JTO Clinical and Research Reports (2024)

Fulltext@MSK | Save

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

Journal Article

Hahn, A. W.; Kotecha, R. R.; Viscuse, P. V.; Pieretti, A. C.; Wiele, A. J.; Jonasch, E.; Lee, C. H.; Gao, J.; Zurita, A. J.; Shah, A. Y.; more...
European Urology Focus (2023)

Fulltext@MSK | Save

Intracranial outcomes of de novo brain metastases treated with osimertinib alone in patients with newly diagnosed EGFR-mutant NSCLC

Journal Article

Imber, B. S.; Sehgal, R.; Saganty, R.; Reiner, A. S.; Ilica, A. T.; Miao, E.; Li, B. T.; Riely, G. J.; Yu, H. A.; Panageas, K. S.; more...
JTO Clinical and Research Reports (2023)

Fulltext@MSK | Save

Outcomes of grade group 2 and 3 prostate cancer on initial versus confirmatory biopsy: Implications for active surveillance

Journal Article

Perera, M.; Jibara, G.; Tin, A. L.; Haywood, S.; Sjoberg, D. D.; Benfante, N. E.; Carlsson, S. V.; Eastham, J. A.; Laudone, V.; Touijer, K. A.; more...
European Urology Focus (2023)

Fulltext@MSK | Save

Prostate-specific antigen density cutoff of 0.15 ng/ml/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: Efficient threshold or legacy of the past?